TCL Archive More Changes In Carcinogenesis Program At NCI: Gori, Workshops Out, Branch Chiefs Running It November 18, 1977
TCL Archive DCT Board Approves Three New BRMP RFAs For Immunologic Research, $1.5 Million A Year February 27, 1987
TCL Archive Five Year Survival Up To 48 Percent; DeVita Has “No Doubt” It Is Really Over 50 Percent Now December 2, 1983
TCL Archive Xeloda, Taxotere, Herceptin Combination May Benefit Invasive Breast Cancer January 25, 2008
